Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Cash from Investing Activities (2021 - 2025)

Biofrontera has reported Cash from Investing Activities over the past 5 years, most recently at $3.0 million for Q4 2025.

  • Quarterly results put Cash from Investing Activities at $3.0 million for Q4 2025, up 300200.0% from a year ago — trailing twelve months through Dec 2025 was $3.0 million (up 560.35% YoY), and the annual figure for FY2025 was $3.0 million, up 100033.33%.
  • Cash from Investing Activities for Q4 2025 was $3.0 million at Biofrontera, up from $1000.0 in the prior quarter.
  • Over the last five years, Cash from Investing Activities for BFRIW hit a ceiling of $3.0 million in Q4 2025 and a floor of -$3.0 million in Q3 2022.
  • Median Cash from Investing Activities over the past 5 years was -$1000.0 (2024), compared with a mean of -$103200.0.
  • Biggest five-year swings in Cash from Investing Activities: crashed 303500.0% in 2022 and later soared 300200.0% in 2025.
  • Biofrontera's Cash from Investing Activities stood at -$9000.0 in 2021, then tumbled by 23077.78% to -$2.1 million in 2022, then skyrocketed by 103.5% to $73000.0 in 2023, then tumbled by 101.37% to -$1000.0 in 2024, then soared by 300200.0% to $3.0 million in 2025.
  • The last three reported values for Cash from Investing Activities were $3.0 million (Q4 2025), $1000.0 (Q3 2025), and -$1000.0 (Q2 2025) per Business Quant data.